By the disease groups, a higher scoring (strength of association) was noted for neoplasms, congenital diseases (mostly driven by the NADSYN1 gene), male and female urogenital diseases and nutritional/metabolic diseases. The gene discussed is NADSYN1; the disease is Other metabolic disease.